The AJMC® Cholangiocarcinoma compendium is a comprehensive resource for clinical news and expert insights about this rare cancer of the bile duct.

Understanding the Unmet Need for Therapies to Treat Rare Bile Duct Cancer

May 24th 2022, 6:14pm


On this episode of Managed Care Cast, we bring you an excerpt of an interview with a co-chair of the 2022 Cholangiocarcinoma Foundation (CCF) annual conference, held earlier this year, about the significant unmet therapy needs facing most patients with this rare cancer.

Alcohol Use, Disease-Free Survival Predictors in Patients With Recurrence of Intrahepatic Cholangiocarcinoma

May 22nd 2022, 3:57am


The study from China sought to evaluate clinical factors associated with survival after recurrence following surgery in ICC.

Biliary Tract Cancer Rates Vary by Country; Prevention Efforts Needed

May 21st 2022, 12:56am


Authors wrote that their analysis was the first to combine incidence and mortality of overall BTC, and its anatomic subtypes, into a single study

City of Hope Faculty Honored for Achievements in Clinical Surgery, Promotion of Women in Cancer Science

May 14th 2022, 10:53pm


Yuman Fong, MD, received the 2022 Flance-Karl Award from the American Surgical Association (ASA), and Leslie Bernstein, PhD, received the Margaret L. Kripke Legend Award for Promotion of Women in Cancer Medicine and Cancer Science.

Treating iCCA With Chemo Pump Can Be as Effective as Surgery, JAMA Study Finds

May 11th 2022, 3:00pm


Cholangiocarcinoma (CCA), or bile duct cancer, is classified by its location, with intrahepatic CCA (iCCA) referring to those cancers that form in bile ducts within the liver.

Screen Patients With CUP for Intrahepatic Cholangiocarcinoma, Study Suggests

May 5th 2022, 1:09pm


In patients with liver involvement, intrahepatic cholangiocarcinoma was a common diagnosis among some patients with cancer of unknown primary (CUP).

European Effort Will Make Cholangiocarcinoma Treatment Info Available in Multiple Languages

May 2nd 2022, 8:47pm


The project seeks to develop materials explaining chemotherapy regimens for patients with biliary tract cancers and then translate these materials into “standardized, high-quality, free, and easily accessible resources."

Cholangiocarcinoma Incidence Doubled in Publicly Funded Health Care System in Texas

April 25th 2022, 9:47pm


Patients were younger and had more advanced disease at diagnosis, according to the study.

CXCR2 Signaling Appears to Have Implications for Cholangiocarcinoma

April 18th 2022, 9:46pm


Expression of the chemokine receptor was linked with better overall survival.

Preclinical Data at AACR Show CSP May Be Broad Target in Cholangiocarcinoma

April 13th 2022, 12:57pm


Researchers presented results for ZB131, a monoclonal antibody that would target cancer-specific plectin (CSP); experiments with mice showed this may be present in more than 80% of the most common types of cholangiocarcinoma.